UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027459
Receipt number R000031448
Scientific Title Efficacy and safety of epicutaneous immunotherapy for severe milk allergy; Long term trial
Date of disclosure of the study information 2017/05/29
Last modified on 2020/08/27 09:11:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety of epicutaneous immunotherapy for severe milk allergy; Long term trial

Acronym

Epicutaneous immunotherapy for milk allergy

Scientific Title

Efficacy and safety of epicutaneous immunotherapy for severe milk allergy; Long term trial

Scientific Title:Acronym

Epicutaneous immunotherapy for milk allergy

Region

Japan


Condition

Condition

Food allergy

Classification by specialty

Clinical immunology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Oral immunotherapy has been shown to have some efficacy in inducing desensitization for patients with severe unremitting food allergy. However, limitation has also been shown in terms of its side effects and difficulty in inducing tolerance. Safer and more effective therapy is needed. In this study, we aim to investigate efficacy and safety of an epicutaneous immunotherapy by using a novel transcutaneous antigen delivery device.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Proportion of the subjects who tolerate more than 3 ml of milk (total dose) at oral milk challenge after the treatment for 48 weeks

Key secondary outcomes

1.Change of dose threshold in oral milk challenge after 24 weeks of treatment
2.Safety:local reaction,systemic immediate-type allergic reaction and other
3.Prick test
4.Specific IgE and IgG4


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Cutaneous application of hydrogel patch containing cow's milk concentrate for 12 hours a day for 48 weeks

Interventions/Control_2

Cutaneous application of hydrogel patch containing cow's milk concentrate for 12 hours a day for 24 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

2 years-old <=

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Milk allergy diagnosed by oral food challenge (OFC) without tendency of natural outgrow

2) Milk dose threshold of OFC =<3ml(total dose) and underwent cutaneous application of cow's milk concentrate-containing hydrogel patch or hydrogel patch without containing antigen for 24 weeks.

3)Milk dose threshold of OFC =<3ml(total dose) after intervetion of 2).

Key exclusion criteria

1)patients who have heart, liver and kidney diseases

2)patients with ncontrolled asthma or atopic dermatitis

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Takao
Middle name
Last name Fujisawa

Organization

National Hospital Organization Mie National Hospital

Division name

Allergy center

Zip code

514-0125

Address

357 Osato-kubota, Tsu, Mie, Japan

TEL

+81592322531

Email

fujisawa@mie-m.hosp.go.jp


Public contact

Name of contact person

1st name Yu
Middle name
Last name Kuwabara

Organization

National Hospital Organization Mie National Hospital

Division name

Allergy center

Zip code

514-0125

Address

357 Osato-kubota, Tsu, Mie, Japan

TEL

+81592322531

Homepage URL


Email

yu_surrealist@hotmail.co.jp


Sponsor or person

Institute

National Hospital Organization Mie National Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

None

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization

Ethics Committees of Mie National Hospital.

Address

357 Osato-kubota, Tsu, Mie, Japan

Tel

+81592322531

Email

fujisawa@mie-m.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構三重病院、国立病院機構相模原病院、福井大学病院、群馬大学病院、獨協医大病院、千葉大学病院、、国立病院機構下志津病院、、千葉県子ども病院、富山大学病院、あいち小児保健医療総合センター、大阪府立呼吸器アレルギー医療センター


Other administrative information

Date of disclosure of the study information

2017 Year 05 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

46

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

Due to organizing data and performing additional analysis.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 05 Month 15 Day

Date of IRB

2017 Year 05 Month 22 Day

Anticipated trial start date

2017 Year 05 Month 29 Day

Last follow-up date

2018 Year 10 Month 31 Day

Date of closure to data entry

2018 Year 12 Month 31 Day

Date trial data considered complete

2019 Year 01 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 05 Month 23 Day

Last modified on

2020 Year 08 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031448


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name